MYRIAD GENETICS INC — DEF 14A

MYRIAD GENETICS INC of SALT LAKE CITY, UT filed a DEF 14A with the SEC on 2022-04-14. Industry: In Vitro & In Vivo Diagnostic Substances.

Filing

Documents (57)

Showing 15 of 57 documents.

SeqTypeDescription
1DEF 14ADEF 14A
2GRAPHICafc.jpg
3GRAPHICafc2.jpg
4GRAPHICafcchairbiggerc.jpg
5GRAPHICafcchairiconbigger.jpg
6GRAPHICafcicon.jpg
7GRAPHICafcicon3.jpg
8GRAPHICatthemeeting.jpg
9GRAPHICbyinternetorphone.jpg
10GRAPHICbyml.jpg
11GRAPHICchart-104fb895a3e740db9d8.jpg
12GRAPHICchart-47b8399c07a04c81b6a.jpg
13GRAPHICchart-547ff38dfda04f2eac9.jpg
14GRAPHICchart-88830f8e6ae4437cbcd.jpg
15GRAPHICchcc.jpg

Filing timeline for this registrant (60)

Showing 12 of 60 filings.

FiledForm
2026-04-14DEFA14A
2026-04-14DEF 14A
2025-04-09DEFA14A
2025-04-09DEF 14A
2024-04-17DEFA14A
2024-04-17DEF 14A
2023-04-12DEFA14A
2023-04-12DEF 14A
2023-03-30PRE 14A
2022-04-14DEFA14A
2022-04-14DEF 14A
2021-04-15DEFA14A

More